A detailed history of Assenagon Asset Management S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 5,174,495 shares of PFE stock, worth $138 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,174,495
Previous 4,766,528 8.56%
Holding current value
$138 Million
Previous $133 Million 12.28%
% of portfolio
0.31%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$27.7 - $31.39 $11.3 Million - $12.8 Million
407,967 Added 8.56%
5,174,495 $150 Million
Q2 2024

Jul 18, 2024

SELL
$25.26 - $29.6 $30.4 Million - $35.7 Million
-1,205,066 Reduced 20.18%
4,766,528 $133 Million
Q1 2024

Apr 24, 2024

SELL
$25.89 - $29.73 $10.4 Million - $11.9 Million
-401,898 Reduced 6.31%
5,971,594 $166 Million
Q4 2023

Jan 17, 2024

BUY
$26.13 - $33.94 $57.3 Million - $74.4 Million
2,191,326 Added 52.4%
6,373,492 $183 Million
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $35.6 Million - $41.6 Million
1,107,971 Added 36.04%
4,182,166 $139 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $137 Million - $159 Million
-3,799,004 Reduced 55.27%
3,074,195 $113 Million
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $145 Million - $189 Million
3,689,877 Added 115.91%
6,873,199 $280 Million
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $385 Million - $502 Million
-9,217,842 Reduced 74.33%
3,183,322 $163 Million
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $456 Million - $557 Million
10,429,412 Added 528.94%
12,401,164 $543 Million
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $122 Million - $145 Million
-2,628,162 Reduced 57.14%
1,971,752 $103 Million
Q1 2022

Apr 25, 2022

BUY
$45.75 - $56.69 $38.2 Million - $47.3 Million
834,467 Added 22.16%
4,599,914 $238 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $279,943 - $414,968
6,775 Added 0.18%
3,765,447 $222 Million
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $18.5 Million - $23.7 Million
470,790 Added 14.32%
3,758,672 $162 Million
Q2 2021

Jul 15, 2021

BUY
$35.91 - $40.68 $118 Million - $134 Million
3,287,882 New
3,287,882 $129 Million
Q1 2021

Apr 26, 2021

SELL
$33.49 - $37.77 $31.3 Million - $35.2 Million
-933,123 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $5.62 Million - $7.14 Million
167,813 Added 21.93%
933,123 $34.3 Million
Q3 2020

Oct 07, 2020

BUY
$31.75 - $37.25 $24.1 Million - $28.2 Million
758,193 Added 10653.27%
765,310 $28.1 Million
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $214,364 - $260,055
7,117 New
7,117 $233,000
Q1 2020

Apr 17, 2020

SELL
$27.03 - $38.62 $2.23 Million - $3.18 Million
-82,455 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$32.92 - $37.36 $2.47 Million - $2.8 Million
74,955 Added 999.4%
82,455 $3.23 Million
Q3 2019

Oct 16, 2019

SELL
$32.49 - $42.13 $107 Million - $138 Million
-3,280,065 Reduced 99.77%
7,500 $269,000
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $121 Million - $136 Million
3,267,565 Added 16337.83%
3,287,565 $142 Million
Q1 2019

Apr 26, 2019

SELL
$37.5 - $41.2 $64.2 Million - $70.5 Million
-1,711,328 Reduced 98.84%
20,000 $849,000
Q4 2018

Jan 23, 2019

SELL
$38.47 - $43.86 $17.3 Million - $19.7 Million
-449,273 Reduced 20.6%
1,731,328 $75.6 Million
Q3 2018

Oct 29, 2018

BUY
$34.47 - $41.81 $64.8 Million - $78.6 Million
1,879,142 Added 623.35%
2,180,601 $96.1 Million
Q2 2018

Jul 17, 2018

SELL
$32.98 - $35.16 $10.9 Million - $11.6 Million
-331,278 Reduced 52.36%
301,459 $10.9 Million
Q1 2018

Apr 30, 2018

BUY
$31.91 - $37.02 $19.1 Million - $22.2 Million
600,096 Added 1838.47%
632,737 $22.5 Million
Q4 2017

Jan 25, 2018

SELL
$33.26 - $35.29 $62.1 Million - $65.9 Million
-1,866,138 Reduced 98.28%
32,641 $1.18 Million
Q3 2017

Oct 18, 2017

BUY
$31.0 - $34.15 $58.9 Million - $64.8 Million
1,898,779
1,898,779 $67.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.